HK Stock Market Move | GENSCRIPT BIO (01548) rose over 5% again. Performance results will be announced in mid-March. Sales of CARVYKTI in the first half of the year increased significantly year-on-year.

10:16 06/08/2026

Kingsoft Biotech (01548) rose over 5% again, and as of the time of publication, it has increased by 3.95%, trading at HKD 19.49, with a transaction volume of HKD 287 million.

GENSCRIPT BIO (01548) rose over 5% again, and as of the time of this report, it was up 3.95% at HKD 19.49, with a turnover of HKD 287 million. In terms of news, GENSCRIPT BIO plans to hold a board meeting on August 15 to approve its interim results. The company previously announced that in the second quarter, sales of Legend Biologics' CARVYKTI reached USD 657 million, an increase of 49.4% year-on-year and a 10% increase quarter-on-quarter. For the first half of the year, sales reached USD 1.254 billion, an increase of 55.1% year-on-year.

HK Stock Market Move | SKB BIO (06990) rose over 4% in the morning as its new dual-load ADC drug SKB565 received approval for clinical trial application.

HK Stock Market Move | Contemporary Amperex Technology (03750) fell over 3% after institutions indicated that the company's gross profit in the second quarter was below expectations, triggering a new round of market concerns.

HK Stock Market Move | Z.AI (02513) surged over 9% during trading as the competition among AI models shifts to comprehensive comparisons. Institutions are optimistic about the companys potential for commercial explosion.

HK Stock Market Move | SKB BIO (06990) rose over 4% in the morning as its new dual-load ADC drug SKB565 received approval for clinical trial application.